Richard Silver to Risk Assessment
This is a "connection" page, showing publications Richard Silver has written about Risk Assessment.
Connection Strength
0.168
-
There is a need for new systemic sclerosis subset criteria. A content analytic approach. Scand J Rheumatol. 2018 Jan; 47(1):62-70.
Score: 0.093
-
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial. Ann Rheum Dis. 2020 05; 79(5):618-625.
Score: 0.028
-
HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry. Proc Natl Acad Sci U S A. 2020 01 07; 117(1):552-562.
Score: 0.027
-
Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis. J Rheumatol. 2005 Oct; 32(10):1888-92.
Score: 0.010
-
Wegener's granulomatosis in patients with rheumatoid arthritis. J Rheumatol. 2003 Sep; 30(9):2064-9.
Score: 0.009